J. Goldman & Co’s Chimerix, Inc. CMRX Stock Holding History

J. Goldman & Co’s Portfolio CMRX Stock Details CMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-254,425	Closed	-$1.57M	–	466
2021 Q3	$1.57M	Buy	+254,425	New	+$1.75M	0.08%	212

Other funds holding CMRX

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

J. Goldman & Co's CMRX Position: Q4 2021 in Review

J. Goldman & Co sold out of Chimerix, Inc. (CMRX) in Q4 2021, closing a stake of 254,425 shares — an estimated $1.57M sold.

J. Goldman & Co first reported a position in CMRX in Q3 2021 and held it in 1 quarter. The position peaked at $1.57M in Q3 2021. 121 funds tracked by Wall St. Rank hold CMRX as of Q4 2021.

J. Goldman & Co reported no remaining Chimerix, Inc. position as of Q4 2021 after selling out during the quarter.
J. Goldman & Co sold 254,425 Chimerix, Inc. shares in Q4 2021, an estimated $1.57M.
J. Goldman & Co first reported a position in Chimerix, Inc. in Q3 2021 and held it in 1 quarter.
J. Goldman & Co's Chimerix, Inc. position peaked at $1.57M in Q3 2021.
121 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q4 2021.

Based on J. Goldman & Co's 13F filing for Q4 2021, filed 14 Feb 2022.